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Abstract A random phage heptapeptide library was screened
with rabbit antibodies against wheat flour proteins comprising
gliadins and a small amount of low molecular weight glutenins
(gli/glu). Gli/glu antibodies isolated from the sera selected
different consensus sequences (CS). All CS contained tri- to
pentapeptide stretches homologous to gli/glu sequences (proposed
epitopes). In K- and Q-type gliadins, these sequences are clustered
in the N-terminal region recently suspected to be toxic for
humans with celiac disease. Peptides with CS were synthesized
and checked for reactivity. Only immune and no control rabbit
sera reacted with synthetic peptides. One of eight human sera
containing gliadin antibodies was reactive as well (4/8 peptides)
but control sera were negative. Thus the phage display technique
is useful for epitope screening of polyclonal antibodies even in the
case of a group of homologous but diverse antigens.
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1. Introduction
Phage display libraries have been shown to be useful tools
to investigate the interaction of ligand with de¢ned molecules
of interest. Until now, phage display libraries have mainly
been used to investigate model systems applying monoclonal
antibodies with the epitopes to be selected known in advance
[1^3] or at least with antigens with known amino acid sequen-
ces [4]. The amino acid sequences selected (phagotopes) do
not necessarily resemble that of the natural antigenic determi-
nant but may mimic a discontinuous epitope (mimotopes). It
would be helpful to apply the technique for elucidation of
antigenic epitopes of antibodies occurring in human diseases.
However, such investigations are complicated because of the
polyclonal nature of these antibodies and because of unknown
antigen. Nevertheless, recently selection of phagotopes has
been described mimicking linear and structural epitopes rec-
ognized by serum-derived antibodies of rabbit [5,6] and man
[7^10].
These results encouraged us to apply random peptide phage
libraries to study antigenic epitopes of antibodies raised
against gliadins. Gliadins are a heterogeneous group of closely
related wheat storage proteins [11]. Therefore, a large number
of di¡erent epitopes recognized by the antibodies may be ex-
pected. In patients with celiac disease, gliadins induce alter-
ations of the small intestinal mucosa which may lead to mal-
absorption, and trigger the synthesis of antibodies against the
wheat proteins and of autoantibodies. In the present report
the epitope speci¢city was investigated of gliadin antibodies
obtained by immunization of rabbits as a model for human
antibodies. The aim of the study was to obtain information
about the immunogenicity of the di¡erent domains of glia-
dins.
The results demonstrate that a number of phagotopes can
be selected that are homologous to primary structures of glia-
dins, very probably representing antigenic epitopes, most of
which are concentrated in the N-terminal region of gliadins.
2. Materials and methods
2.1. Gliadin and gliadin antibodies
A preparation of gliadins was obtained from wheat cv. Kanzler
[12]. According to SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) [13] and immunoblot [14] the resulting product (gli/glu) con-
tained ethanol extractable gliadins (K-, Q-, g-type) known to be ac-
companied by minor amounts of gliadin-related low molecular weight
(LMW) glutenins [11]. Rabbits were immunized with gli/glu [15]. Im-
munoglobulin G was isolated from rabbit sera by a⁄nity chromatog-
raphy on protein A. Antibodies against gli/glu (gliadin antibodies)
were a⁄nity puri¢ed using gli/glu coupled to A⁄gel-10 (Bio-Rad,
Munich, Germany). Starting from 10 ml rabbit serum, 90 mg total
IgG and 1.5 mg gliadin antibodies were obtained. Purity and speci¢c-
ity of isolated gliadin antibodies were checked by SDS-PAGE and
immunoblot.
2.2. Phage display and sequencing
The Ph.D. Phage Display Peptide Library Kit (New England Biol-
abs, Schwalbach, Germany, version 1.5) was used as described [4].
After three rounds of selection, 36, 34, 67, or 65 clones (experiments
3, 9, 17, 18, respectively) were isolated and ampli¢ed. The DNA was
isolated and cycle-sequenced using primers according to the instruc-
tions of the manufacturers.
2.3. Enzyme immunoassay of gliadin antibodies
Human gliadin antibodies of the IgA and IgG class were deter-
mined by enzyme immunoassay in microwells coated with gliadin as
described previously [15]. The results are expressed as percentage of
reactivity of a control serum provided by Labmaster (Turku, Fin-
land). For assay of rabbit gliadin antibodies, microwells were incu-
bated with rabbit serum (diluted 1:100 to 1:25 000) and binding of
immunoglobulins was demonstrated by pig anti-rabbit immunoglobu-
lins conjugated with peroxidase (1:2000, DAKO, code P217). Serum
dilution at half maximal binding is indicated as titer.
2.4. Determination of endomysium antibodies (EmA)
IgA class EmA were determined on monkey esophagus sections
(Virimmun, Frankfurt, Germany) [16].
2.5. Synthesis of cellulose-bound peptides and antibody binding studies
Peptides covalently bound to a cellulose membrane via their C-
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termini were prepared by automated spot synthesis [17] as previously
described in detail [18]. After washing in methanol and bu¡er (TBS-T:
NaCl 137 mM, KCl 2.7 mM, Tris 50.4 mM, Tween 0.05%, pH 8.0)
membranes were blocked, washed in TBS-T and incubated in rabbit
serum (1:100). After further washing membranes were incubated with
anti-rabbit immunoglobulins conjugated with peroxidase (DAKO,
code P217, 1:500 in TBS-T). After washing luminescence was meas-
ured using the Supersignal CL-HPR kit according to the instructions
of the manufacturer (Pierce, Rockford, IL, USA, code 34080) on
Hyper¢lm-ECL (Amersham, Braunschweig, Germany). Binding was
assessed qualitatively as positive (+) or negative (3).
2.6. Homology search
The database of the National Center of Biotechnology Information
(NCBI Bethesda, MD, USA, release March 18, 1998) was searched
using the Advanced BLAST program [19]. The data base comprised
294 713 individual sequences with a total of 88 550 842 letters and
containing 43 entries for K-type gliadins with a total of 11 895 amino
acids, 18 entries for Q-type gliadins with a total of 4418 amino acids,
and seven entries for low molecular weight glutenins with 1914 amino
acids. Only entries comprising peptides of at least 200 amino acids in
length but no short fragments were considered. These gliadin/LMW
glutenin (gli/glu) sequences were used for further homology search
with consensus sequences (CS) obtained by phage display. Sequences
were considered CS if they contained identical amino acids in at least
three positions and they occurred in at least three independent phage
clones. If there were several overlapping motifs identical to gli/glu
sequences within the CS, priority was given to the longest sequence.
Similarity of amino acids was considered according to the BLO-
SUM62 substitution matrix [20].
3. Results
In ELISA, immune sera of all rabbits showed a high titer of
gliadin antibodies. In immunoblot, the antibodies reacted with
a large number of gliadin fractions in the molecular weight
range between 30 and 80 kDa and sera of the di¡erent ani-
mals produced very similar staining patterns. Serum of con-
trol rabbits showed low reactivity in ELISA and produced no
staining in immunoblots (data not shown).
The amino acid composition of sequenced peptide inserts
after panning with gliadin antibodies from four rabbits was
di¡erent from that of the naive library. Glutamine was over-
represented by a factor of 2.7^7.7 in peptide inserts obtained
from three rabbits, which is in accordance with the high pro-
portion of this amino acid in gliadins. For all four rabbits the
proline content was between 14 and 21%, which is close to
that reported for gliadins.
The sequences of the selected peptides were grouped into
CS (Table 1). Antibodies from di¡erent rabbits selected up to
three di¡erent CS. All CS extended over the complete phag-
otope of seven amino acids. In two of the CS (9/1 and 18/1),
tetrapeptide motifs were found in di¡erent positions within
the heptapeptide. Between 4 and 18% of all sequences could
not be grouped into a CS. After panning on immunoglobulins
derived from serum of a control rabbit no CS was obtained.
CS were compared with gli/glu sequences. Several tri-, tetra-
, and pentapeptide stretches of CS were found that were ho-
mologous to gli/glu sequences. From CS 18/1 two possible
epitopes were postulated dependent on substitution of Q in
the epitope by E in the phagotope.
The frequency with which the proposed epitopes occurred
in a gli/glu molecule was calculated as the mean number per
gli/glu molecules. Further, the total data base was screened for
homology with peptide motifs showing homology with glia-
dins. A ratio was calculated between total data base entries
and those entries comprising the group of prolamins. The
ratio was small for tripeptide motifs (6 0.007) but high for
tetra- and pentapeptide motifs (mean value 0.2 or 0.5, respec-
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Fig. 1. Distribution of postulated epitopes in K-type and Q-type gliadin, and LMW glutenin sequences. The occurrence of di¡erent epitopes at
speci¢ed positions in the sequence is indicated as mean frequency by bars (horizontal lines indicate variation of epitope position within the dif-
ferent K-type and Q-type gliadin and LMW glutenin species). A mean frequency of 1 means that all currently known sequences of K-type and
Q-type gliadins and LMW glutenins contain the proposed epitope once at the speci¢ed position. Dotted lines below the x-axis show the location
of disul¢de bridges. In K- and Q-type gliadins epitopes are clustered in the N-terminal region.
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tively). 84% of all entries containing the sequence QQPFP
were prolamins.
Peptides with CS were synthesized and tested for binding to
rabbit sera (Table 2). None of the immune sera recognized all
of the peptides. Sera which were used for selection of phage
bound to at least one of the selected peptides. One peptide
was recognized by all sera applied for biopanning experi-
ments, two peptides were recognized by none. Testing of fur-
ther sera positive for gliadin antibodies revealed binding of
two sera to two peptides. Rabbit control sera reacted with
none of the peptides.
To investigate if sequences recognized by rabbit antibodies
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Table 1
Consensus sequences (CS) selected in biopanning experiments and postulated epitopes in gli/glu
Experiment n Amino acid sequence Mean frequencya
K Q LMW
3 CS 30 G P Y S L L L
I 97 100 100 93 60 100 70
S 97 100 100 95 63 100 97
Epitope P Y S 0.33 0.00 0.00
I* 100 100 93
S* 100 100 95
9 CS 1 10 W M E Q P F P
I 20 30 90 50 100 100 100
S 20 60 100 80 100 100 100
Epitope Q Q P F P 0.67 4.16 0.57
I* 10 50 100 100 100
S* 100 80 100 100 100
CS 2 16 L Q Q F P E L
I 56 75 100 100 100 100 69
S 69 75 100 100 100 100 75
Epitope Q Q F P Q 0.00 1.22 0.00
I* 75 100 100 100 0
S* 75 100 100 100 100
17 CS 1 47 N T Q Q P W Q
I 28 100 100 79 100 40 26
S 47 100 100 79 100 74 38
Epitope S Q Q P Y 0.81 0.00 0.00
I* 0 100 79 100 15
S* 100 100 79 100 91
CS 2 11 T Q E W L P Q
I 45 91 100 27 100 100 100
S 45 100 100 27 100 100 100
Epitope L P Q 1.27 0.17 1.42
I* 100 100 100
S* 100 100 100
CS 3 7 Q I G Q Q V P
I 100 71 100 100 57 43 47
S 100 100 100 100 86 43 57
Epitope Q L G Q Q 0.00 0.00 1.00
I* 100 29 100 100 57
S* 100 100 100 100 86
18 CS 1 34 Y W P F P E Q G
I 9 12 21 100 100 100 91 41
S 21 18 21 100 100 100 91 41
Epitope P E Q 0.95 0.11 0.43
I* 100 100 91
S* 100 100 91
Epitope F P Q Q 0.00 2.44 0.57
I* 100 100 0 91
S* 100 100 100 91
CS 2 20 A H M N P S P
I 32 100 100 47 37 21 21
S 37 100 100 74 37 58 21
Epitope M N P 0.00 0.33 0.00
I* 100 47 37
S* 100 74 37
I : Percentage of the most common amino acid at a speci¢ed position in the CS. If there were two amino acids with the same frequency, the amino
acid that had a higher number of similar amino acids at the respective position was further considered. S : Percentage of amino acids similar or
identical to the most common amino acid (positive according to the BLOSUM62 substitution matrix). I* : Percentage of amino acids in the
consensus phagotope identical to the corresponding amino acid in the gli/glu sequences. S* : Percentage of amino acids at a speci¢ed position of the
phagotope similar to gli/glu. Peptide motifs in CS matching gli/glu sequences are printed in bold. n : Number of clones selected with CS.
aMean frequency of epitope motifs per molecule of K-type and Q-type gliadins and of LMW glutenins. CS 1 from experiment 18 comprised eight
amino acids because the consensus occurred in shifted positions within the heptapeptide.
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are epitopes for human gliadin antibodies as well, the reac-
tivity of human sera positive for gliadin antibodies was com-
pared with human control sera (Table 3). Only one of the
gliadin antibody positive sera bound to four of the peptides.
Interestingly, AHMNPSP, which was not reactive with rabbit
sera, was recognized by human sera, too. Human control sera
did not bind.
4. Discussion
The presence of linear epitopes in gli/glu was expected be-
cause all rabbit sera recognized proteins in ethanolic £our
extracts after reduction and treatment with SDS. In keeping
with that, several short contiguous stretches of 3^5 amino
acids were selected that were homologous with gli/glu sequen-
ces. The degree of homology between the selected phagotopes
and antigenic molecules was comparable with recent observa-
tions [6,8,9].
The signi¢cance of the selected CS as gli/glu sequences can
be recognized from their frequency in gli/glu molecules. Fur-
ther, for the homologous tetra- and pentapeptide motifs most
of the entries in the total data base were connected with glia-
dins and with related prolamins from related cereal species
like rye, barley, and oats. Taken together this strongly implies
that selected phagotopes mimic gli/glu sequences.
Selected linear regions in CS matched well homologous re-
gions in gli/glu sequences. However, the tripeptide homology
of GPYSLLL, TQEWLPQ, and AHMNPSP with gli/glu may
be too small to account for binding. In these peptides, several
amino acids at positions outside the region of homology to
gli/glu were selected. Thus, amino acids may contribute to the
epitope more distant from the linear array but brought into
the close vicinity by the room structure of the antigen. Alter-
natively, tripeptide homology may exist purely by chance with
the single amino acids as constituents of a mimotope.
However, a contribution of discontinuous epitopes to the
antigenic repertoire of gliadin antibodies cannot be ruled out.
To discover epitopes comprising a large number of discontin-
uous antibody binding points, libraries with longer peptide
inserts may be better suited [21].
Several stretches of CS are homologous to more than one
region in gliadin molecules. This is due to the repetitive struc-
ture of N-terminal domain Ib of gli/glu [10]. Thus, FPQQ and
QQPFP are contained in Q-type gliadins on average three and
four times, respectively. Therefore, the question arises if cor-
responding antibodies recognize only one or all of the homol-
ogous regions. Furthermore, QQPFP is found in K-type glia-
dins and LMW glutenins, too. Speci¢city for only one region
would mean that amino acids in the neighborhood are impor-
tant for recognition as well. Reactivity with more than one
region of homology would mean a repetitive epitope structure
and imply a high e¡ectivity of binding of antibodies. Screen-
ing of binding sites on proenkephalin revealed more than one
epitope region recognized by monoclonal antibody due to the
repetitive structure of the protein [21].
Experiments with synthetic peptides demonstrate that the
selected linear sequences represent structures recognized solely
by sera obtained after immunization of rabbits with gliadin
but not by control sera. This con¢rms the speci¢city of the
selected peptide sequences as gli/glu epitopes. The sera already
used in phage display experiments recognized a larger number
of peptides in the luminescence assay than four further ran-
domly chosen sera. This ¢nding could be due the fact that the
eight peptides were preselected by biopanning. This suggests
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Table 2
Reactivity of rabbit immune sera against eight di¡erent synthetic peptides with sequences according to the consensus sequences from the phage
display experiments
Serum Use in biopanning
experiment no.
GPYSLLL WMEQPFP LQQFPEL NTQQPWQ TQEWLPQ QIGQQVP YWPFPEQG AHMNPSP
R60a 3 +a + 3 + 3 + + 3
R46 9 3 +a +a 3 3 3 + 3
R60b 17 + + 3 +a 3a 3a + 3
R61 18 3 + + 3 3 3 +a 3a
R22 3 3 3 3 + 3 3 3 3
R47 3 3 3 + + 3 3 3 3
R63 3 3 3 3 3 3 3 3 3
R69 3 3 3 + 3 3 3 3 3
Gliadin antibodies from the upper four sera were used for biopanning experiments.
aSequence selected from corresponding antibodies during biopanning. Eight rabbit control sera were tested as well for reactivity with the peptides
with negative results.
Table 3








GPYSLLL WMEQPFP LQQFPEL NTQQPWQ TQEWLPQ QIGQQVP YWPFPEQG AHMNPSP
H356 174 49 + 3 3 3 3 3 3 3 3
H542 135 68 + 3 3 3 3 3 3 3 3
H496 79 0 + 3 3 + 3 + + 3 +
H1267 172 47 + 3 3 3 3 3 3 3 3
H180 232 47 + 3 3 3 3 3 3 3 3
H1370 40 165 3 3 3 3 3 3 3 3 3
Five human control sera were tested as well for reactivity with the peptides with negative results.
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the existence of further antigenic epitopes recognized by glia-
din antibodies in the latter sera. Thus LQQFPEL and
NTQQPWQ may represent more often recognized epitope
speci¢cities whereas other sequences seem to be restricted to
individual sera. Further, dominant clones may have over-
grown less frequent ones during selection which may explain
di¡erences in the epitope repertoire indicated in Tables 1 and
2.
Experiments with human antisera revealed that only one of
them contained antibodies reacting with the selected peptides.
Nevertheless, this serum recognized four of the peptides at the
same time, including LQQFPEL which was also bound by a
large number of rabbit antisera, and AHMNPSP which was
reactive with none of the rabbit sera in the luminescence as-
say. The di¡erent epitope speci¢city of human and rabbit
antisera may be explained by di¡erent ways of immunization,
i.e. gastrointestinal vs. intracutaneous, which may include dif-
ferent processing and presentation of antigen.
The distribution of postulated linear epitopes over gli/glu
sequences shows clustering in the N-terminal part of K- and Q-
type gliadins (Fig. 1). K- and Q-type gliadins contain three and
four disul¢de bridges, respectively, leading to the formation of
loops and of a compact structure in the C-terminal part of the
molecules [22] which may be less accessible to B-cell response
than the N-terminal region. Thus, at least for antibodies rec-
ognizing linear epitopes or epitopes containing a linear com-
ponent, the N-terminal region may possess a high antigenicity.
Interestingly, short sequence stretches in the N-terminal re-
gion of K-type gliadins are suspected to be responsible for
toxicity of gliadins in celiac patients [23]. Further investiga-
tions are currently being performed to examine the epitope
speci¢city of human gliadin antibodies.
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